LONDON (Reuters) -British scientific instruments maker Spectris has agreed to a sweetened offer from U.S. private equity firm ...

The sweetened offer comes days after Advent improved its bid for Spectris, prompting the target to withdraw its ...

In June, a bidding war for Spectris began with an initial offer from Advent. After KKR entered the fray with its own bid, the British company's board repeatedly changed its recommendation between the ...

Precision instrumentation supplier Spectris said on Thursday that second-quarter momentum and strategic cost savings had ...

KKR ups its bid for Spectris to £4.2 billion, overtaking Advent in a fierce takeover race for the UK scientific instruments ...

British scientific instruments maker Spectris SXS.L has agreed to private equity firm Advent's sweetened takeover offer worth ...

Private equity giant KKR has trumped rival Advent's takeover bid for British scientific instruments maker Spectris with an ...

Cognito Therapeutics Presents Clinical Trial Data Highlighting Neuroprotective Potential of Spectris™ in Alzheimer’s Disease ...

Spectris has failed to achieve such ratings as a public company due to weaker profitability, low scale and relative ...

US private equity group’s offer nudges out rival bidder once again in race to acquire UK scientific instruments maker ...

The private equity bidding war for precision instrument business Spectris has stepped up a gear after New York-based KKR ...

Advent International has outbid KKR in a private equity bidding war for Spectris after the UK industrial group accepted its ...